Boston Scientific Corp. (BSX) Dividend History

Company News

• Peripheral Vascular Devices Market Report 2025: Global Trends, Opportunities, and Forecast, 2020-2030 - Advanced Devices Like ACUSON AcuNav Volume 4D ICE Catheter Broaden Vascular Intervention Options

  The peripheral vascular devices market is expected to grow significantly due to the rising prevalence of peripheral artery disease and diabetes, as well as technological advancements in devices like drug-eluting stents and bioresorbable scaffolds. However, the market faces challenges from stringent regulatory requirements.

  GlobeNewswire Inc.

  Featured Companies: ABT
• Boston Scientific Raises Annual Outlook After Strong Heart Devices Sales In Q1, Announces CFO Transition

  Boston Scientific reported strong Q1 results, with revenue and earnings beating estimates. The company's cardiovascular segment saw a 26.2% sales growth, driven by a 29.8% jump in cardiology products. Boston Scientific also raised its annual outlook and announced a CFO transition.

  Benzinga
• Baxter (BAX) Q2 Earnings Beat Estimates, '24 EPS View Raised

  Baxter International Inc. reported better-than-expected Q2 2024 earnings, with adjusted EPS of 68 cents beating the consensus estimate. Revenue also topped expectations, driven by growth across the company's business segments. The company provided positive guidance for Q3 and full-year 2024.

  Zacks Investment Research

  Featured Companies: BAX HOLX UHS